IBOK
IMGN

Independence Bank of Kentucky’s Immunogen Inc IMGN Stock Holding History

Independence Bank of Kentucky’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-200
Closed -$2K – 388
2018
Q1 		$2K Buy
+200
New +$1.98K ﹤0.01% 376

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Independence Bank of Kentucky's IMGN Position: Q2 2018 in Review

Independence Bank of Kentucky sold out of Immunogen Inc (IMGN) in Q2 2018, closing a stake of 200 shares — an estimated $2K sold.

Independence Bank of Kentucky first reported a position in IMGN in Q1 2018 and held it in 1 quarter. The position peaked at $2K in Q1 2018. 198 funds tracked by Wall St. Rank hold IMGN as of Q2 2018.

  • Independence Bank of Kentucky reported no remaining Immunogen Inc position as of Q2 2018 after selling out during the quarter.
  • Independence Bank of Kentucky sold 200 Immunogen Inc shares in Q2 2018, an estimated $2K.
  • Independence Bank of Kentucky first reported a position in Immunogen Inc in Q1 2018 and held it in 1 quarter.
  • Independence Bank of Kentucky's Immunogen Inc position peaked at $2K in Q1 2018.
  • 198 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2018.

Based on Independence Bank of Kentucky's 13F filing for Q2 2018, filed 7 Aug 2018.